CTLA-4 can function as a negative regulator of T cell activation
- 1 August 1994
- Vol. 1 (5) , 405-413
- https://doi.org/10.1016/1074-7613(94)90071-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The B7 and CD28 receptor familiesImmunology Today, 1994
- Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.The Journal of Experimental Medicine, 1992
- Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation MoleculeScience, 1992
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lgScience, 1992
- CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.The Journal of Experimental Medicine, 1992
- Disparate interaction of peptide ligand with nascent versus mature class I major histocompatibility complex molecules: comparisons of peptide binding to alternative forms of Ld in cell lysates and the cell surface.The Journal of Experimental Medicine, 1992
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991
- Role of the CD28 receptor in T-cell activationImmunology Today, 1990
- T90/44 (9.3 antigen). A cell surface molecule with a function in human T cell activationEuropean Journal of Immunology, 1986
- Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors.The Journal of Experimental Medicine, 1979